Lise Duranteau

ORCID: 0000-0001-9434-248X · 6 papers in corpus
2025
BMJ (Clinical research ed.) ·doi:10.1136/bmj-2024-083981

ObjectiveTo assess the risk of intracranial meningioma associated with oral contraceptives containing desogestrel, levonorgestrel, or levonorgestrel combined with oestrogen.DesignCase-control study.SettingFrench national health data system …

2025
European journal of neurology ·doi:10.1111/ene.16505

Background and purposeChlormadinone acetate (CMA) is a synthetic progestin for which cases of intracranial meningioma have been reported following prolonged exposure.MethodAn observational cohort study was conducted based on the French nati…

2024
BMJ (Clinical research ed.) ·doi:10.1136/bmj-2023-078078

ObjectiveTo assess the risk of intracranial meningioma associated with the use of selected progestogens.DesignNational case-control study.SettingFrench National Health Data System (ie, Système National des Données de Santé).ParticipantsOf 1…

2023
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics ·doi:10.1002/ijgo.14438

ObjectiveTo assess the user profiles of copper intrauterine devices (Cu-IUD) and levonorgestrel intrauterine systems (LNG-IUS) in France in 2019 and the rates of continuation 1 year later.MethodsA population-based study was conducted of all…

2022
European journal of neurology ·doi:10.1111/ene.15423

Background and purposeA dose-dependent association between the use of cyproterone acetate (CPA) and intracranial meningioma has been identified but data for other potent progestogens are scarce. The association was assessed between intracra…

article 2021
·doi:10.1016/j.perped.2021.03.030